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52 
ABSTRACT: 53 
 54 
Nine Brazilian Amaryllidaceae species were studied for their alkaloid composition and 55 
acetylcholinesterase (AChE) inhibitory activity via GC–MS and a modified Ellman assay, respectively. 56 
A total of thirty-six alkaloids were identified in these plants, of which Hippeastrum papilio and H. 57 
glaucescens exhibited the highest galanthamine content and the best IC50 values against AChE. 58 
Furthermore, Hippeastrum vittatum and Rhodophiala bifida also showed notable AChE inhibitory 59 
effects. X-ray crystallographic data for four galanthamine-type compounds revealed significant 60 
differences in the orientation of the N-methyl group, which are shown to be related to AChE inhibition. 61 
 62 
 63 
64 
INTRODUCITON 65 
 66 
The Amaryllidaceae alkaloids represent a large group of isoquinoline alkaloids derived from the 67 
common biogenetic precursor O-methylnorbelladine through oxidative phenolic coupling, leading to 68 
eight distinct structural-types (Bastida et al. 2006). The galanthamine- type skeleton has been the focus 69 
of numerous studies since the AChE inhibitor galanthamine was approved by the FDA for the clinical 70 
management of mild to moderate Alzheimer’s disease (AD) (Maelicke et al. 2001). Although the 71 
chemical synthesis of galanthamine has been achieved on several occasions, natural sources still 72 
constitute the bulk of its commercial supply chain (Berkov et al. 2011). Apart from this, the other 73 
structural representatives of the Amaryllidaceae are known for a diverse array of biological activities 74 
including, antitumoral, antiviral, antiparasitic, anti-inflammatory, psychopharmacological and 75 
interactions with human cytochrome P450 3A4 (Vrijsen et al. 1986; C  ¸itog˘lu et al. 1998; da Silva et al. 76 
2006; McNulty et al. 2007, 2009; Zupko´ et al. 2009; Giordani et al. 2010). These attributes have 77 
showcased the Amaryllidaceae as a promising resource for new and bioactive molecules. 78 
The high resolution power of the capillary column technique in gas chromatography (GC) together with 79 
the ready availability of libraries of electron impact mass spectrometry (EI–MS) data in the literature 80 
facilitate the rapid identification and quantification of known alkaloids. This has been shown to be 81 
particularly useful to studies of the Amaryllidaceae, extracts of which contain a large number of 82 
alkaloids (Kreh et al. 1995; Wagner et al. 2003). To this extent, several southern Brazilian 83 
Amaryllidaceae species have been examined for their alkaloid content and biological activity (da Silva 84 
et al. 2006, 2008; Pagliosa et al. 2010; Giordani et al. 2011a, b; de Andrade et al. 2011). In the present 85 
study, a GC–MS analysis was undertaken on nine Amaryllidaceae species which allowed for the 86 
identification of thirty-six alkaloids belonging to seven skeleton-types. Furthermore, an AChE inhibitory 87 
activity assay was carried out with both isolated compounds and alkaloid-rich fractions. In addition, X-88 
ray crystallographic analysis was carried out on some galanthamine derivatives, providing insights to the 89 
structural features attending AChE activity. 90 
91 
MATERIALS AND METHODS 92 
 93 
Chemicals 94 
Galanthamine (27) and 11b-hydroxygalanthamine (32) used for X-ray crystallography were previously 95 
obtained from Hippeastrum papilio (de Andrade et al. 2011). Sanguinine (28) and narwedine (31) were 96 
obtained in previous works from Crinum kirkii Chemicals Galanthamine (27) and 11b-97 
hydroxygalanthamine (32) used for X-ray crystallography were previously obtained from Hippeastrum 98 
papilio (de Andrade et al. 2011). Sanguinine (28) and narwedine (31) were obtained in previous works 99 
from Crinum kirkii (Machocho et al. 2004) and Leucojum aestivum (Berkov et al. 2008a), respectively. 100 
MeOH (HPLC grade), CHCl3, Me2CO, H2SO4 and NH4 ? (analytical grade) were purchased from SDS 101 
(France). Acetylthiocholine iodide (ATCI), acetylcholinesterase (AChE) from electric eels (type VI-S 102 
lyophilized powder), and 5,5 V-dithiobis[2-nitrobenzoic acid] (DTNB) were obtained from Sigma-103 
Aldrich Chemie (Steinheim, Germany). The n-hydrocarbon mixture (C9–C36, Restek, Cat no. 31614) 104 
was supplied by Teknokroma (Spain). Galanthamine (purity[99 %) used for the calibration curves was 105 
previously obtained by the authors, and codeine (purity C 99 %) used as internal standard was purchased 106 
from Sigma Aldrich (St. Louis, MO, USA). 107 
 108 
Plant material 109 
The species H. papilio (Ravenna) Van Scheepen (bulbs and leaves, UFRGS–ICN 149428), Hippeastrum 110 
vitattum (L’He´r.) Herb. (bulbs, UFRGS–ICN 8889), Hippeastrum striatum (Lam.) Moore (bulbs, 111 
UFRGS–ICN 9549), Hippeastrum morelianum Lem. (bulbs, UNICAMP–UCE 14351), Hippeastrum 112 
santacarina (Traub) Dutilh (bulbs, UFRGS–ICN 149429), Hippeastrum breviflorum Herb. (bulbs, 113 
UFRGS–ICN 9190), Hippeastrum glaucescens (Mart.) Herbert (bulbs and leaves, UFRGS–ICN 8894), 114 
Hippeastrum psittacinum Herb. (bulbs and leaves, UNICAMP–UCE 143513) and Rhodophiala bifida 115 
(Herb.) Traub (bulbs, UNICAMP–UCE 136352) were collected and the extracts obtained according to 116 
previously described methods (Castilhos et al. 2007; da Silva 2005; da Silva et al. 2008; Pagliosa et al. 117 
2010; Giordani et al. 2011a, b; de Andrade et al. 2011; Sebben 2005). 118 
 119 
Sample preparation 120 
The plant material (1 g) was crushed and extracted by stirring at rt with MeOH (3 9 50 ml), the 121 
combined macerate filtered and evaporated to dryness under reduced pressure. The crude extract was 122 
acidified to pH 2 with 2 % H2SO4, neutral material removed using Et2O (3 9 25 ml). The aqueous 123 
phase was then basified up to pH 11 with NH3 (25 %, v/v) and extracted with CHCl3 (3 9 25 ml) to 124 
afford the chloroform extract. 125 
 126 
 127 
 128 
GC–MS and identification of alkaloids 129 
The chloroform extract (300 ll) was filtered and then used for subsequent GC–MS analysis. EI–MS 130 
spectra were obtained on an Agilent 6890 N GC 5975 inert MSD operating in EI mode at 70 eV (Agilent 131 
Technologies, Santa Clara, California, USA) utilizing a DB-5 MS column (30 m 9 0.25 mm 9 0.25 lm, 132 
Agilent Technologies) with an injector temperature  of 280 C. The temperature program was as 133 
follows: 100–    180 C at 15 Cmin-  1, 1 min hold at 180 C and 180–    300 C at 5 Cmin-1 and 10 min 134 
 hold at 300 C. The flow rate of carrier gas (Helium) was 0.8 ml min-1 and a split ratio of 1:20 was 135 
followed. The alkaloids were identified by comparing their GC–MS spectra and Kovats retention indices 136 
(RI) with our in-house library database. This library has been continually updated and reviewed with 137 
alkaloids isolated by our group and identified using other spectroscopic techniques such as NMR, UV, 138 
CD and MS. Mass spectra were deconvoluted using AMDIS 2.64 software (NIST). Kovats retention 139 
indexes (RI) of the compounds were recorded with standard calibration of an n-hydrocarbon mixture 140 
(C9–C36). 141 
The proportion of each individual component in the alkaloid fractions analysed by GC–MS (Table 1) is 142 
expressed as a percentage of the total alkaloids (TIC—total ion current). The area of the GC–MS peak 143 
depends not only on the concentration of the corresponding compound but also on the intensity of its 144 
mass spectral fragmentation. Although data given in Table 1 do not express a real quantification, they 145 
can nevertheless be used for a relative comparison of the alkaloids. 146 
Quantification of galanthamine in H. papilio The quantification was performed in triplicate using 50 mg 147 
of dried material (leaves and bulbs, separately) and codeine as i.s. (50 lg) in screw-top 2.0 ml Eppendorf 148 
tubes. The maceration procedure was carried out with 1 ml of MeOH adjusted to pH 8 with NH3 (25 %, 149 
v/v). After 2 h of extraction at room temperature assisted by 15 min ultrasonic baths every 30 min, the 150 
samples were centrifuged at 10,000 rpm for 2 min. An aliquot of 500 ll of methanolic macerate was 151 
acidified with 500 ll of H2SO4 (2 %, v/v) and neutral material removed with chloroform (2 9 500 ll). 152 
The aqueous fraction was then basified with 200 ll of NH3 (25 %, v/v) and alkaloids extracted with 153 
CHCl3 (3 9 500 ll). Finally, the purified alkaloid extract was dried under N2 and redissolved in 100 ll of 154 
CHCl3 for GC–MS analysis. The GC–MS conditions were the same used for the alkaloid-rich extract 155 
(Section GC–MS and identification of alkaloids). 156 
Recovering and repeatibility of the extraction The extraction recovery was performed as described 157 
above by adding 50, 300 and 500 lg of galanthamine to the dry plant sample (50 mg of powdered bulbs 158 
and leaves of H. papilio) before the extraction and purification. Intraday (n = 4) and interday (n = 8) 159 
repeatability was calculated with 50 mg of dried powdered bulbs of H. papilio, extracted, purified and 160 
analysed via GC–MS on two different days according to Berkov et al. (2008b). 161 
 162 
Samples for X-ray 163 
Narwedine (31) and 11b-hydroxygalanthamine (32) were dissolved in CHCl3 under a pentane 164 
atmosphere  and left in the freezer (less than 5 C) for a week. Sanguinine (28) was dissolved in a 165 
MeOH:EtOH mixture (1:1, v/v) under a pentane atmosphere and left  in the freezer (less than 5 C) for 166 
two weeks. Galanthamine (27) was dissolved in Me2CO and left in the freezer for a week. Suitable 167 
crystals for X-ray analysis were preselected under a light microscope. The crystallographic data of 27 168 
and 31 were in agreement with those previously reported (Carrol et al. 1990; Hemetsberger et al. 2004). 169 
 170 
X-Ray analysis for sanguinine (28) 171 
A translucent prism-like specimen of sanguinine with the dimensions 0.192 mm 9 0.278 mm 9 0.457 172 
mm was used for X-ray crystallographic analysis. First, the X-ray intensity data were determined, with a 173 
total of 171 frames collected at an exposure time of 1.71 h. The frames were integrated with the Bruker 174 
SAINT software package using a narrow-frame algorithm. The integration of the data using a 175 
monoclinic unit cell yielded a total of 19,735 reflections to a maximum  h angle of 30.67  (0.70 A ° 176 
resolution), of which 7366 were independent (average redundancy 2.679, completeness = 94.1 %,Rint = 177 
4.80 %, Rsig = 5.54 %) and 6597 (89.56 %) were greater than 2r(F2). The final cell constants of a = 178 
9.227(6) A ° , b = 15.095(8) A ° ,  c = 9.750(5) A ° , b = 102.28(3) , volume = 1327.(2) A ° 179 
3, are based upon the refinement of the XYZcentroids of 142 reflections above 20 r(I) with 180 
 4.944 \2h\  49.15 . Data were corrected for absorption effects using the multi-scan method (SADABS). 181 
The ratio of minimum to maximum apparent transmission was 0.757. 182 
The structure was solved and refined using the Bruker SHELXTL Software Package, with Z = 2 for the 183 
formula unit, C16H19NO3. The final anisotropic full-matrix least-squares refinement on F2 with 375 184 
variables converged at R1 = 4.08 %, for the observed data and wR2 = 10.17 % for all data. The 185 
goodnessof- fit was 1.047. The largest peak in the final difference electron density synthesis was 0.382 186 
e-/A ° 3 and the largest hole was -0.274 e-/A°3 with an RMS deviation of 0.058 e-/A° 3. On the basis of 187 
the final model, the calculated density was 1.367 g/cm3 and F(000), 584 e-. 188 
 189 
X-Ray analysis for 11b-hydroxygalanthamine (32) 190 
A prismatic crystal (0.1 9 0.09 9 0.08 mm) was selected and mounted on a MAR345 diffractometer with 191 
an image plate detector. Unit-cell parameters were determined from 107 reflections (3\h\318) and 192 
refined by the least-squares method. Intensities were collected with graphite monochromatized Mo Ka 193 
radiation. 8529 reflections were measured in the range 2.44 B h B 24.10, 2419 of which were non-194 
equivalent by symmetry (Rint(on I) = 0.045). 2135 reflections were assumed as observed applying the 195 
condition I[2r (I). Lorentz-polarization was considered, but no absorption corrections were made. The 196 
structure was solved by direct methods, using the SHELXS computer program (Sheldrick 2008) and 197 
refined by the full-matrix least-squares method with the SHELX97 computer program (Sheldrick 2008), 198 
using 8529 reflections, (very negative intensities were not assumed). The function minimized was R w 199 
||Fo|2 - |Fc|2 |2, where w = [r2(I) ? (0.0683P)2]-1, and P = (|Fo|2 ? 2 |Fc|2)/3, f, f’ and f’’ were taken 200 
from International Tables of X-Ray Crystallography (1974). All H atoms were computed and refined, 201 
using a riding model, with an isotropic temperature factor equal to 1.2 times the equivalent temperature 202 
factor of the atom which are linked. The final R(on F) factor was 0.047, wR(on |F|2) = 0.117 and 203 
goodness of fit = 1.069 for all observed reflections. The number of refined parameters was 200. Max. 204 
shift/esd = 0.00, mean shift/esd = 0.00. Max. and min. peaks in final difference synthesis were 0.395 and 205 
-0.169 e.A° -3, respectively. 206 
 207 
AChE inhibitory activity 208 
The assay for measuring AChE inhibitory activity was performed as described by Lo´pez et al. (2002). 209 
Galanthamine hydrobromide was used as a positive control. A solution of the initial alkaloid-rich extract 210 
(chloroform fraction) at 1 mg/ml was taken up in MeOH and diluted further with phosphate buffer to 211 
give 100, 10, 1, 0.1, 0.01, 0.001 lg/ml solutions. Only IC50 values less than 100 lg/ml were considered. 212 
Compounds 27, 28, 31, and 32 were used in dilutions at the range of 10-8 to 10-3 M. Dilutions at 10-4 213 
M were prepared in MeOH and further dilutions were carried out using phosphate buffer. IC50 of all 214 
extracts/compounds were measured in triplicate and the results are presented as a mean ± standard 215 
deviation using the software package Prism (Graph Pad Inc., San Diego, USA). 216 
 217 
218 
Results and discussion 219 
 220 
GC–MS results 221 
GC–MS analysis has here proved to be a robust and efficient technique for the rapid identification and 222 
quantification of a large number of alkaloids from Amaryllidaceae plant extracts. In this study, nine 223 
Brazilian species were analysed and thirty-six compounds belonging to seven skeleton-types were 224 
identified (see Fig. 1; Table 1). 225 
Lycorine- and homolycorine-type: an ‘ortho-para’ phenolic coupling 226 
As the lycorine skeletal-type is widely distributed in the Amaryllidaceae, it was surprising to find few 227 
representatives of this group in the Hippeastrum species and Rodophiala bifida surveyed. The alkaloid 228 
lycorine (3) is known to be poorly soluble in both CHCl3 and MeOH, which impedes its correct 229 
quantification by GC–MS (de Andrade et al. 2012). This might explain the low relative percentage 230 
observed for H. santacatarina (19.18 %, see Table 1), in contrast with a recent study of the same species, 231 
in which it was isolated as the main compound (Giordani et al. 2011b). Overall, homolycorine-type 232 
alkaloids were observed in higher variety and quantity, indicating that conversion of lycorine- to 233 
homolycorine-type alkaloids is an active chemical transformation in these species. 234 
 235 
Crinine-, haemanthamine-, tazettine-, narciclasine- and montanine-type alkaloids: a ‘para-para’ phenolic 236 
coupling 237 
A major mechanistic consideration in the biosynthesis of Amaryllidaceae alkaloids is ‘para-para’ 238 
coupling, since it gives rise to five distinct skeleton-types. The crinine-type skeleton is uncommon in the 239 
genus Hippeastrum and the absolute configuration of its 5,10b-ethano bridge is ratified only by CD 240 
spectra or X-ray crystallography (Wagner et al. 1996). As shown in Table 1 and Fig. 1, the 5,10b-241 
ethanophenanthridinealkaloids described in this study possess the haemanthamine- type skeleton as 242 
previously confirmed (da Silva et al. 2008; de Andrade et al. 2011; Giordani et al. 2011a). 243 
With respect to the tazettine skeleton, there are important features concerning epimerisation at C-3. 244 
Duffield et al. (1965) showed that the stereochemistry of the substituent at C-3 effects marked variations 245 
in the relative abundance of ions in EI-MS spectra. The b-configuration of the methoxyl group at C-3 246 
facilitates a Retro-Diels–Alder (RDA) process in ring-B and loss of the neutral fragment [C5H8O], 247 
yielding diagnostic ion peaks at 247 and m/z 231 (M–84) for tazettine (19) and deoxytazettine (17), 248 
respectively. The fragment ion at m/z 70 is a small peak for both epimers (Duffield et al. 1965). As such, 249 
the ion peak at m/z 70 for criwelline and 16 is much more pronounced than those observed in 17 and 19, 250 
indicating that compound 16 is the 3-epideoxytazettine variant. The a-configuration of the 3-OMe 251 
substituent also induces a RDA fragmentation process, but in this case with the loss of the [C4H8N]? 252 
fragment, while the m/z 70 ion peak abundance establishes the C-3 configuration in tazettine derivatives 253 
(Duffield et al. 1965). 254 
In general, montanine-type alkaloids are sparsely encountered and are thus poorly represented in the 255 
Amaryllidaceae. However, montanine (25) was here found as the main constituent in H. vittatum and R. 256 
bifida, while trisphaeridine (23) was the only representative of the narciclasine-type skeleton detectable 257 
as a minor compound or in trace amounts in most species (Table 1). Trisphaeridine has been considered 258 
a catabolic product (Bastida et al. 2006) and this hypothesis is supported by its presence in many species 259 
but hardly ever as the main alkaloid. Galanthamine-type alkaloids: a ‘para-ortho’ phenolic coupling 260 
Galanthamine-type compounds were found mainly in H. papilio and H. glaucescens, with galanthamine 261 
(27) being the main constituent in both cases (Table 1). Galanthamine was previously detected in H. 262 
papilio (de Andrade et al. 2011), but it is here reported for the first time in H. glaucescens. The 263 
remaining galanthamine-type representatives were detected in both species, but to a lesser extent. 264 
Miscellaneous alkaloids Ismine (34) and galanthindole (35) were identified in H. breviflorum, H. 265 
morelianum, H. psittacinum and H. glaucescens. Alkaloid 34, like 23, is also considered a catabolic 266 
product arising from the haemanthaminetype skeleton (Bastida et al. 2006). Galanthindole (35) and 267 
lycosinine B (36) have been considered representatives of a new skeleton containing a non-fused indole 268 
ring (U¨ nver 2007), although the possibility that they are artifacts of homolycorine- or tazettine-type 269 
derivatives cannot be overlooked. 270 
 271 
Galanthamine quantification 272 
H. papilio and H. glaucescens showed highest levels of galanthamine by GC–MS (Table 1) and the 273 
availability of H. papilio allowed the accurate quantification of galanthamine content from dried plant 274 
material. Bulbs and leaves exhibited values of 0.51 % (±0.012) and 0.33 % (±0.007), respectively (mg 275 
GAL/100 mg DW). These values are larger than those observed for Galanthus and Leucojum species 276 
used commercially by pharmaceutical companies for extraction of galanthamine (Cherkasov and 277 
Tolkachev 2002; Berkov et al. 2008b, 2009). The extraction recovery was 95 % (RSD 1.73 %), 93 % 278 
(RSD 2.20 %) and 91 % (RSD 0.81 %) for 50, 300 and 500 lg of added galanthamine, respectively. 279 
Intra-day repeatability (n = 4) expressed as RSD was determined as 1.60 for the first day and 2.21 for 280 
the second, while inter-day repeatability (n = 8) was 2.94 with adequate values of precision (RSD\5 %). 281 
 282 
AChE inhibitory assay for alkaloid-rich extracts 283 
The results from the microplate AChE inhibition assay of plant extracts are shown in Table 2. H. papilio 284 
and H. glaucescens presented the lowest IC50 values as determined via the Ellman method (Section ChE 285 
inhibitory activity). These are stronger activities than those observed for Galanthus elwesii and G. 286 
nivalis (at 0.1 and 10 lg/ml) as well as Leucojum aestivum (at 10 lg/ml) (Berkov et al. 2008c). The 287 
possibility of false-positive results in the AChE inhibitory activity values due to chemical inhibition 288 
(Rhee et al. 2003) should not be ruled out. 289 
H. vittatum and R. bifida, in which elevated levels of montanine were detected, also exhibited notable 290 
AChE inhibitory effects (Table 2). Montanine (25) has previously demonstrated remarkable activity 291 
against AChE obtained from rat brain, with more than 50 % inhibition at 1 mM (Pagliosa et al. 2010). 292 
These results, together with psychobiological activities reported earlier for montanine (da Silva et al. 293 
2006), reinforce the potential of montanine-type derivatives as therapeutic candidates for AChE 294 
inhibition or other functions related to the central nervous system (da Silva et al. 2006; Pagliosa et al. 295 
2010). 296 
 297 
X-ray crystallography and AChE assay for galanthamine-derivatives 298 
In agreement with previous reports (Lo´pez et al. 2002; Berkov et al. 2008c), galanthamine (27) and 299 
sanguinine (28) (Fig. 4) were the most active AChE inhibitory alkaloids (IC50s 0.35 and 0.06 lM, 300 
respectively). Narwedine (31) and 11b-hydroxygalanthamine (32) showed IC50 values of 9.38 and 3.49 301 
lM, respectively. Some studies have been carried out to understand the binding of galanthamine and 302 
galanthamine-type alkaloids at the AChE active site (Bartolucci et al. 2001; Greenblatt et al. 1999). 303 
Although these have provided useful insights to the binding of the aromatic methoxyl group, the furan 304 
and cyclohexene rings as well as the 3-hydroxyl substituent, the effects of the N-methyl group remain 305 
largely unresolved. However, it is noteworthy that galanthamine adopted the same conformation at the 306 
active site gorge as that determined by X-ray crystallographic analysis (Bartolucci et al. 2001; Carrol et 307 
al. 1990). 308 
The X-ray data obtained for galanthamine (27) and narwedine (31) are in agreement with previously 309 
published work (Carrol et al. 1990; Hemetsberger et al. 2004). The X-ray data for sanguinine (28)1 and 310 
11b-hydroxygalanthamine (32)2 are reported here for the first time. Interestingly, narwedine (31) and 311 
11bhydroxygalanthamine (32) (Fig. 2) showed an axial orientation for the NMe group, opposite to that 312 
seen for galanthamine. Sanguinine (28) (Fig. 3), the most potent AChE inhibitor known from the 313 
Amaryllidaceae, exhibited both orientations for the NMe group with 50 % of the molecules having the 314 
NMe group in the axial orientation and the other 50 % with the equatorial orientation. AChE inhibition 315 
curves together with the X-ray structures of all tested galanthamine alkaloids are shown in Fig. 4. 316 
 317 
318 
CONCLUSIONS 319 
 320 
Some indigenous Brazilian species are shown to produce high quantities of the AChE inhibitors 321 
galanthamine and montanine. Following the approval of galanthamine by the FDA for clinical 322 
management of AD, galanthamine-type alkaloids have been the most commonly studied constituents of 323 
the Amaryllidaceae. Herein is reported for the first time the high levels of galanthamine detected via 324 
GC–MS in H. glaucescens. Galanthamine levels in leaves and bulbs of H. papilio were higher than those 325 
found in Leucojum, Galanthus and Narcissus, species traditionally used for commercial exploitation 326 
(Berkov et al. 2009). In addition, H. papilio and H. glaucescens extracts showed the lowest IC50 AChE 327 
inhibition values. Since evidence from docking studies of galanthamine analogs are inconclusive, further 328 
investigation is required to clarify the role of N-methyl orientation at the AChE active site gorge 329 
(Bartolucci et al. 2001). Galanthamine has the N-methyl group in an equatorial disposition and showed 330 
better AChE inhibitory activity than narwedine and 11b-hydroxygalanthamine, wherein the N-methyl 331 
group is axially-orientated. Chlidanthine also displays an axial orientation for the N-methyl group and 332 
exhibits noticeably lower AChE inhibition (IC50 24.1 lM) (Reyes-Chilpa et al. 2011). However, 333 
sanguinine exhibits the best IC50 inhibition values and has the N-methyl group in both axial and 334 
equatorial orientations. It is known that N-methyl conformers interchange rapidly in the naturally bound 335 
ligand, thereby restricting N-methyl orientation to a secondary role in new drug design. Nevertheless, 336 
further protein–ligand crystallography and protein–ligand docking studies should clarify the exact role 337 
of N-methyl orientation in galanthamine-type alkaloids. 338 
 339 
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Legends to figures 430 
 431 
Fig. 1 Alkaloids found in the Brazilian species 432 
 433 
Fig. 2 ORTEP projection of 11b-hydroxygalanthamine (32) 434 
 435 
Fig. 3 Top, a view of the molecular structure of compound 3. Bottom, the labeled core of the cubane. 436 
Bonds depicted in orange correspond to the short Cu–O distances inside the {Cu4O4} cage and the 437 
dashed red bonds show the H-bonds involving the coordinated water molecule 438 
 439 
Scheme 3 ORTEP projection of sanguinine (28) 440 
 441 
Fig. 4 Acetylcholinesterase inhibition curve and X-ray structures of sanguinine, galanthamine, 11b-442 
hydroxygalanthamine and narwedine showing the N-methyl orientation 443 
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Table 2 AChE inhibitory activity of the alkaloid extracts 486 
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